By Finance Pulse in Transformative —

Pfizer Opts Out of New Hemophilia A Gene Therapy

Pfizer pulls back on developing a new gene therapy for hemophilia A, citing limited market interest. Explore the implications for the hemophilia community and biotech sector.

A sleek, modern illustration of DNA strands, symbolizing gene therapy, intertwined with a muted, pro
Pfizer Opts Out of New Hemophilia A Gene Therapy

Pfizer's decision was due to a belief of limited interest in an additional gene therapy for hemophilia A.

Source